Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interests: Christian Bahrs is a member of the scientific advisory board of GSK and reports personal fees from Pfizer for lectures and has received supports for attending meetings and travel, all outside the submitted work.
Conflict of interest: Miriam Kesselmeier have declared no conflict of interest.
Conflict of interests: Martin Kolditz reports personal fees from Berlin Chemie, Boehringer, Astrazeneca, Biotest, Novartis, GSK, Gilead, Pfizer and MSD and a research grant from Pfizer outside the submitted work.
Conflict of interests: Santiago Ewig is member of the scientific advisory board of Pfizer.
Conflict of interests: Gernot Rohde reports personal fees from Astrazeneca, Berlin Chemie, BMS, Pfizer, Boehringer Ingelheim, Solvay, Insmed, GSK, Essex Pharma, MSD, Grifols, Chiesi, Vertex, Roche, Takeda and Novartis for lectures including service on speakers’ bureaus outside the submitted work and/or consultancy during advisory board meetings and personal fees from GSK for travel accommodations/meeting expenses, outside the submitted work.
Conflict of interests: As part of her activity as a member of the executive bodies, Grit Barten-Neiner reports economic connections to the following diagnostic and pharmaceutical companies: ThermoFisher Scientific/BRAHMS, Alere Technologies GmbH, Merck Sharp & Dohme Corp., Pfizer Pharma GmbH, R-Biopharm AG and Helmut Hund GmbH.
Conflict of interest: Jan Rupp has nothing to disclose.
Conflict of interest: Martin Witzenrath received personal fees from Astrazeneca, Bayer Health Care, Berlin Chemie, Biotest, Chiesi, Novartis, Teva, and research funding from Actelion, Bayer Health Care, Biotest, Boehringer Ingelheim, all unrelated to the current work.
Conflict of interest: Tobias Welte is the head of clinical studies and a member of the speakers’ bureau for Pfizer, Bio Merieux and Roche Diagnostics and is a consultant to Pfizer and MSD.
Conflict of interest: Mathias W. Pletz is a consultant to and a member of the speakers’ bureau for Bayer, MSD, Pfizer, meduptodate, Thermofisher and Novartis and has received research grants from Pfizer.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received September 7, 2021.
- Accepted November 1, 2021.
- Copyright ©The authors 2021. For reproduction rights and permissions contact permissions{at}ersnet.org